Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Chembiochem : a European Journal of Chemical Biology|February 4, 2011
NMR studies of DOXP reductoisomerase and its inhibitor complexNadine E Englert, Christian Richter, Jochen Wiesner, et al.
FEBS Letters|June 5, 2003
Microbial isoprenoid biosynthesis and human gammadelta T cell activationMatthias Eberl, Martin Hintz, Armin Reichenberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2012
Primary MHC-class II(+) cells are necessary to promote resting Vδ2 cell expansion in response to (E)-4-hydroxy-3-methyl-but-2-enyl-pyrophosphate and isopentenyl pyrophosphateNatalia Soriano-Sarabia, Hakon Sandvold, Hassan Jomaa, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2007
Synthesis and evaluation of alpha,beta-unsaturated alpha-aryl-substituted fosmidomycin analogues as DXR inhibitorsVincent Devreux, Jochen Wiesner, Hassan Jomaa, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 3, 2004
Determination of fosmidomycin in human serum and urine by capillary electrophoresisStéphane Bronner, Corinne Renault, Martin Hintz, et al.
FEBS Letters|November 6, 2013
Structure of the (E)-4-hydroxy-3-methyl-but-2-enyl-diphosphate reductase from Plasmodium falciparumIngo Rekittke, Elena Olkhova, Jochen Wiesner, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2003
Structure-activity relationships of novel anti-malarial agents. Part 6: N-(4-arylpropionylamino-3-benzoylphenyl)-[5-(4-nitrophenyl)-2-furyl]acrylic acid amidesJochen Wiesner, Katharina Fucik, Katja Kettler, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2003
Acyloxyalkyl ester prodrugs of FR900098 with improved in vivo anti-malarial activityRegina Ortmann, Jochen Wiesner, Armin Reichenberg, et al.
Archiv Der Pharmazie|July 5, 2005
Alkoxycarbonyloxyethyl ester prodrugs of FR900098 with improved in vivo antimalarial activityRegina Ortmann, Jochen Wiesner, Armin Reichenberg, et al.
Pageof 8